{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:22:38Z","timestamp":1787678558314,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110235","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:59:51Z","timestamp":1783627191000},"page":"110235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated in silico and SPR-based workflow identifies FDA-approved drugs as previously unrecognized SIRT3 binders"],"prefix":"10.1016","volume":"180","author":[{"given":"Rocco","family":"Buccheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piperno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rescifina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110235_bb0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single Ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110235_bb0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.procbio.2024.05.024","article-title":"Recent advancement of analytical approaches for assessing Ataxia telangiectasia mutated kinase inhibitors in Ataxia telangiectasia: an overview","volume":"144","author":"Rameshkumar","year":"2024","journal-title":"Process Biochem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102808","article-title":"Targeting the ATM pathway in cancer: opportunities, challenges and personalized therapeutic strategies","volume":"129","author":"Lee","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2026.110235_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-024-12766-7","article-title":"Biomarkers in Ataxia-telangiectasia: a systematic review","volume":"272","author":"Tiet","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bioorg.2026.110235_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134444","article-title":"Clinical and genetic spectrum of Ataxia telangiectasia Tunisian patients: Bioinformatic analysis unveil mechanisms of ATM variants pathogenicity","volume":"278","author":"Jenni","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0040","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/mds.27319","article-title":"Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations","volume":"33","author":"Levy","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bioorg.2026.110235_bb0045","doi-asserted-by":"crossref","DOI":"10.7750\/BioDiscovery.2012.1.3","article-title":"Targeting ATM pathway for therapeutic intervention in cancer","author":"Khalil","year":"2012","journal-title":"Biodiscovery"},{"key":"10.1016\/j.bioorg.2026.110235_bb0050","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2011-08-373639","article-title":"Mitochondrial dysfunction in ataxia-telangiectasia","volume":"119","author":"Valentin-Vega","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.110235_bb0055","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.7150\/thno.97320","article-title":"Mitochondrial Sirtuins in Cancer: A revisited review from molecular mechanisms to therapeutic strategies","volume":"14","author":"Shen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2026.110235_bb0060","doi-asserted-by":"crossref","first-page":"21159","DOI":"10.1038\/s41598-020-78193-6","article-title":"SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma","volume":"10","author":"Bhalla","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110235_bb0065","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1021\/acs.jmedchem.4c01053","article-title":"A mitochondria-targeting SIRT3 inhibitor with activity against diffuse large B cell lymphoma","volume":"67","author":"Jana","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cmdc.201900594","article-title":"Repurposing of FDA-approved drugs for treating iatrogenic botulism: A paired 3D-QSAR\/docking approach\u2020","volume":"15","author":"Floresta","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110235_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","article-title":"GNINA 1.3: the next increment in molecular docking with deep learning","volume":"17","author":"McNutt","year":"2025","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2026.110235_bb0080","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3390\/molecules30163361","article-title":"High-throughput, high-quality: benchmarking GNINA and AutoDock Vina for precision virtual screening workflow","volume":"30","author":"Buccheri","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110235_bb0085","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/molecules23051038","article-title":"Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?","volume":"23","author":"Ram\u00edrez","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110235_bb0090","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1021\/jm500777s","article-title":"Discovery of potent and selective Sirtuin 2 (SIRT2) inhibitors using a fragment-based approach","volume":"57","author":"Cui","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0095","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/acs.jmedchem.5b01376","article-title":"5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 inhibitors","volume":"59","author":"Ai","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0100","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.bmcl.2018.06.029","article-title":"Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma","volume":"28","author":"Fournier","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110235_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116328","article-title":"Identification of isoform\/domain-selective fragments from the selection of DNA-encoded dynamic library","volume":"45","author":"Zhou","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104768","article-title":"Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry","volume":"110","author":"Loharch","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107729","article-title":"Mechanism of inhibition of the human Sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies","volume":"9","author":"Guan","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110235_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249470","article-title":"An integrated pharmacophore\/docking\/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors","volume":"21","author":"Gentile","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110235_bb0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12859-021-04076-w","article-title":"SAveRUNNER: an R-based tool for drug repurposing","volume":"22","author":"Fiscon","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.bioorg.2026.110235_bb0130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.chembiol.2013.09.019","article-title":"Crystal structures of Sirt3 complexes with 4\u2032-Bromo-resveratrol reveal binding sites and inhibition mechanism","volume":"20","author":"Nguyen","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0135","doi-asserted-by":"crossref","first-page":"12475","DOI":"10.1038\/s41598-024-63177-7","article-title":"Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer","volume":"14","author":"Ullah","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110235_bb0140","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/ijms21072601","article-title":"Structural insight into the interactions between structurally similar inhibitors and SIRT6","volume":"21","author":"Zhao","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.bioorg.2026.110235_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116999","article-title":"Discovery of novel compounds as potent activators of Sirt3","volume":"73","author":"Reverdy","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0150","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acs.jcim.0c01193","article-title":"Elucidation of structural determinants delineates the residues playing key roles in differential dynamics and selective inhibition of Sirt1\u20133","volume":"61","author":"Singh","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110235_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006705","article-title":"Inherent versus induced protein flexibility: comparisons within and between apo and holo structures","volume":"15","author":"Clark","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0160","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.bioorg.2026.110235_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S0033583512000066","article-title":"Protein flexibility in docking and surface mapping","volume":"45","author":"Lexa","year":"2012","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.bioorg.2026.110235_bb0170","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3389\/fphar.2018.00923","article-title":"Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview","volume":"9","author":"Salmaso","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.microc.2009.05.001","article-title":"Microfluidic networks for surface plasmon resonance imaging real-time kinetics experiments","volume":"93","author":"Grasso","year":"2009","journal-title":"Microchem. J."},{"key":"10.1016\/j.bioorg.2026.110235_bb0180","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1038\/s41598-019-45166-3","article-title":"Label-free flow multiplex biosensing via photonic crystal surface mode detection","volume":"9","author":"Petrova","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110235_bb0185","series-title":"Intrinsically Disordered Proteins","first-page":"611","article-title":"Determination of binding kinetics of intrinsically disordered proteins by surface Plasmon resonance","author":"Leth","year":"2020"},{"key":"10.1016\/j.bioorg.2026.110235_bb0190","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.2174\/0929867330666230116162646","article-title":"The use of surface Plasmon resonance to study the interactions ofProteins involved in conformational diseases: ExperimentalApproaches for new Therapeutical perspectives","volume":"30","author":"Zingale","year":"2023","journal-title":"CMC"},{"key":"10.1016\/j.bioorg.2026.110235_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/bios15010035","article-title":"Surface plasmon resonance-based biodetection systems: principles, progress and applications\u2014a comprehensive review","volume":"15","author":"Butt","year":"2025","journal-title":"Biosensors"},{"key":"10.1016\/j.bioorg.2026.110235_bb0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11468-024-02343-z","article-title":"Design of surface plasmon resonance (SPR) sensors for highly sensitive biomolecular detection in cancer diagnostics","volume":"20","author":"S","year":"2025","journal-title":"Plasmonics"},{"key":"10.1016\/j.bioorg.2026.110235_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118621","article-title":"Modelling-filtered drug repurposing and first-in-protein SPR validation of histone deacetylase 4 inhibitors for Ataxia-telangiectasia","volume":"192","author":"Distefano","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110235_bb0210","series-title":"Handbook of Surface Plasmon Resonance","year":"2017"},{"key":"10.1016\/j.bioorg.2026.110235_bb0215","article-title":"Caffeine targets SIRT3 to enhance SOD2 activity in mitochondria","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0220","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1021\/acs.jmedchem.3c00337","article-title":"Novel 1,4-Dihydropyridines as specific binders and activators of SIRT3 impair cell viability and Clonogenicity and downregulate hypoxia-induced targets in Cancer cells","volume":"66","author":"Zwergel","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41392-024-01816-1","article-title":"2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis","volume":"9","author":"Peng","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bioorg.2026.110235_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13659-022-00323-6","article-title":"The bibenzyl derivatives of Dendrobium officinale prevent UV-B irradiation induced photoaging via SIRT3","volume":"12","author":"Chen","year":"2022","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.bioorg.2026.110235_bb0235","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1007\/s12325-024-02839-4","article-title":"A practical review of Encorafenib and Binimetinib therapy Management in Patients with BRAF V600E-mutant metastatic non-small cell lung Cancer","volume":"41","author":"Baik","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bioorg.2026.110235_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13701","article-title":"MEK inhibitors block growth of lung tumours with mutations in ataxia\u2013telangiectasia mutated","volume":"7","author":"Smida","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110235_bb0245","first-page":"141","article-title":"A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors","volume":"75","author":"Hage Chehade","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110235_bb0250","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241298541","article-title":"Cancer biomarkers and precision oncology: a review of recent trends and innovations","volume":"18","author":"AlDoughaim","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.1988.6.2.191","article-title":"The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia","volume":"6","author":"Rivera","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110235_bb0260","doi-asserted-by":"crossref","first-page":"2025094","DOI":"10.20517\/microstructures.2025.71","article-title":"Bench-to-bedside translation of podophyllotoxin-based nanomedicines for cancer treatment: utopias and reality?","volume":"5","author":"Wang","year":"2025","journal-title":"Microstructures"},{"key":"10.1016\/j.bioorg.2026.110235_bb0265","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.2147\/IJN.S335482","article-title":"Formulation and pathohistological study of mizolastine\u2013solid lipid nanoparticles\u2013loaded ocular hydrogels","volume":"16","author":"El-Emam","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2026.110235_bb0270","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2026.110235_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1493","article-title":"Extended tight-binding quantum chemistry methods","volume":"11","author":"Bannwarth","year":"2021","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110235_bb0280","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/ci300604z","article-title":"Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise","volume":"53","author":"Koes","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110235_bb0285","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110235_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062731","article-title":"Steered molecular dynamics simulations study on FABP4 inhibitors","volume":"28","author":"Tomarchio","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110235_bb0295","doi-asserted-by":"crossref","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","article-title":"DGIdb 5.0: rebuilding the drug\u2013gene interaction database for precision medicine and drug discovery platforms","volume":"52","author":"Cannon","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110235_bb0300","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2010.872","article-title":"Genomic organization and localization of the NAD-dependent histone deacetylase gene sirtuin 3 (Sirt3) in the mouse","volume":"38","author":"Mahlknecht","year":"2011","journal-title":"Int. J. Oncol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:40:48Z","timestamp":1787676048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0045206826007716"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110235","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated in silico and SPR-based workflow identifies FDA-approved drugs as previously unrecognized SIRT3 binders","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110235"}}